Claire read the email twice before she let herself believe it.
Deborah Koh had copied the entire subcommittee roster into the body — eleven names, university chairs, a former FDA deputy commissioner, the chief medical officer of a health system in Seattle — and beneath the signature, one line in Deborah's own voice, not the tidy form-letter tone of the rest: *The seat is yours if you want it. The first meeting is the second Tuesday of the month. I should tell you it is not a ceremonial appointment.*
"She wrote that on purpose," Claire said, tilting the laptop toward Ethan. They were in her kitchen, and it was late enough that the window over the sink had turned into a black mirror. She'd been halfway through reheating something and had abandoned it. "That's the part she wants me to read. *Not ceremonial.*"
Ethan read it standing, one hand flat on the counter like he was bracing. He'd come straight from a twelve-hour shift; there was still a pen in the pocket of his scrubs. "Is it?"
"Is it what?"
"Not ceremonial. When they put you on a national board — the actual work, or the letterhead with your name under it."
Claire pulled the laptop back. Outside, Marlborough Street was quiet; a car went by, water hissing off its tires. "You're asking the wrong person. I'm the one who said yes to Kessler for three years because the letterhead looked good on a slide."
"You didn't say yes to Kessler. You said yes to the work, and Kessler took credit for it." Ethan opened the refrigerator, found nothing he wanted, closed it. "Different thing."
She watched him do it. There was something in the restless way he moved through her kitchen now — drawer, cabinet, the flat of his hand testing the counter — that she'd learned to read over the past months. It wasn't hunger. It was the residue of a hard day he hadn't talked about yet, and she'd decided a long time ago not to make him talk about it before he was ready.
"Two Tuesdays a month," she said. "D.C. and one rotating site. Plus the reading. Deborah was honest about the reading — forty hours before the first meeting. Cases, dockets, adverse-event filings."
"That's a real number."
"It's a real number."
Ethan finally sat down across from her, elbows on the table. "So take it."
"Just like that."
"Claire." He said her name the way he said very few things — flat, but only because he meant all of it. "You spent a year proving that a model can be right and still kill people because nobody was looking at the input. There isn't going to be a second thing in your whole career that matters more than being the person who looks. If the seat is open and they're offering it to somebody who's actually done the work—" He shrugged. "You'd be an idiot not to take it."
"And the part where I'm gone two Tuesdays a month and buried in reading the other twenty-eight days?"
"That's the part I was getting to."
She waited.
"I don't love it," Ethan said. "I'm not going to pretend I love it. We just started being—" he gestured vaguely, meaning the two of them, meaning the gala and the grave and the fact that half of Boston had watched them walk into a ballroom together. "Whatever this is. I'd like more of it, not less."
"Okay."
"But Rachel's paper is out. And you keep saying the sequel is the rural cohort, and I believe you. And this—" he tapped the edge of the laptop, "—this is the thing that stops the next Patient 146 before the next model ships. So yes. Take it. I'll figure out the rest."
Claire sat with that for a second. Then she closed the laptop and stood up and went around the table and put her arms around his shoulders from behind, her chin against his hair. He smelled like hospital — that specific antiseptic-and-coffee smell that she'd once thought was the least romantic thing in the world and had since come to associate, irrationally, with him.
"Say it again," she said quietly.
"Which part."
"*I'll figure out the rest.*"
"I'll figure out the rest," Ethan said, and she felt his hand come up to cover hers.
She called Miriam Akerman the next morning before her first meeting, standing in the stairwell of the Helix building because it was the only place on her floor without a window into somebody's desk.
"I'm taking the subcommittee seat."
"Good," Miriam said, not a second's hesitation. "That's the right call and I would have told you so."
She was a dozen years older than Claire, an epidemiologist who had spent her career in rural health systems and had the sun-damaged forearms of someone who'd driven a lot of county roads. Claire had met her once, at the gala, and trusted her within ten minutes, which was faster than she trusted almost anyone.
"But," Miriam said.
"But the grant application is Sunday."
"Before nine Monday morning, yes. And the committee meets Tuesday. Which means if this—" she meant the story, the docket filing, the dissenting report; she meant whatever was going to happen next week, "—breaks before Tuesday, the committee is going to read about my lead investigator in the newspaper before they read her name on the application. You understand that's a different application than the one we discussed a month ago."
"I understand."
"Do you? Because I'll tell you what I've learned in twenty years of funding small things: the money doesn't go to the best science. It goes to the science that doesn't make anybody nervous. And a young researcher in the middle of a national fight—" Miriam exhaled. "I'm not saying no. I'm saying I need to know by Sunday whether your name is on it."
"It will be."
"Say that with something behind it."
"Dr. Akerman." Claire heard her own voice go harder than she'd intended. "I've been the person who made everybody comfortable for eight years. I'm not doing it anymore."
There was a pause. Then Miriam laughed, short and dry. "Okay," she said. "Sunday."
Deborah Koh's office called the next afternoon to confirm the appointment, and the confirmation came with a calendar attachment: first meeting, second Tuesday, eleven hundred pages of pre-read materials in a shared drive, and a note that the subcommittee would open with a review of the FDA's new draft guidance — the guidance that cited Claire's own paper.
She sat with that for a while. It was a strange feeling, being the author of the thing you were about to be asked to judge.
Ethan came over that night with takeout and found her at the kitchen table with the laptop open to the first case file — a sepsis-prediction system, three hundred pages of validation data, a footnote on page forty-one that she'd already highlighted twice.
"Page forty-one," Ethan said, setting the bag down.
"Page forty-one."
"What's on page forty-one?"
"Nothing yet. That's why I've highlighted it." She looked up at him. "This is going to be like this for a while. The reading, I mean. I'm going to be bad company."
"You're already bad company. You alphabetize your spice rack."
"I do not—" She stopped. Ethan was smiling, the small one that only showed up when he'd decided to be pleased about something and didn't want to make a production of it. "That's not fair."
"Take the seat, Bennett." He pulled a chair out. "Eat something. Page forty-one will still be there."
She did. They ate with the laptop open between them and the file glowing, and at some point Ethan started asking her questions about the validation data, and she answered, and it turned into the kind of conversation they had when the work was good — two people leaning over the same page, arguing about a confidence interval, neither of them watching the clock.
When he left, a little after midnight, he stopped in the doorway.
"Second Tuesday," he said.
"Second Tuesday."
"I'll be here when you get back."
Claire stood in the hall a moment after the door closed. Then she went back to the table and opened page forty-one again.
It was only when she was finally going to bed, at two in the morning, that she checked her phone and saw the notification she'd missed four hours earlier.
*Sarah Whitfield:* Helix comms is preparing a statement. It goes out Monday morning. They're naming you.